Zanosar
(Streptozocin sterile powder)
| General Information: Zanosar is typically
utilized in the treatment of metastatic islet cell carcinoma of the
pancreas. For indication, dosing or other information, please
refer to the manufacture package insert. |
| |
|
Product |
Size |
NDC Number |
PI |
MSDS |
| Zanosar |
1g/20mL |
00703-4636-01 |
PI |
MSDS |
|
| |
| Clinical
Data: For any questions
or for further information
related to Zanosar, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |